Role of liraglutide in Alzheimer’s disease pathology

BACKGROUND: The described relationship between Alzheimer’s disease (AD) and type 2 diabetes (T2D) and the fact that AD has no succesful treatment has led to the study of antidiabetic drugs that may limit or slow down AD pathology. MAIN BODY: Although T2D treatment has evident limitations, options ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Vargas-Soria, Maria, Carranza-Naval, Maria Jose, del Marco, Angel, Garcia-Alloza, Monica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Mini Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199799/
https://www.ncbi.nlm.nih.gov/pubmed/34118986
http://dx.doi.org/10.1186/s13195-021-00853-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199799/
https://www.ncbi.nlm.nih.gov/pubmed/34118986
http://dx.doi.org/10.1186/s13195-021-00853-0

Ejemplares similares